Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of an online support program to help female cancer patients manage their health and illness: Protocol for a randomized controlled trial.
Mizuno M, Chiba I, Mukohara T, Kondo M, Maruo K, Ohigashi T, Naruo M, Asano Y, Onishi T, Tanabe H, Muta R, Mishima S, Okano S, Yuda M, Hosono A, Ueda Y, Bando H, Itagaki H, Ferrans CE, Akimoto T. Mizuno M, et al. Among authors: ueda y. Contemp Clin Trials Commun. 2022 Nov 10;30:101035. doi: 10.1016/j.conctc.2022.101035. eCollection 2022 Dec. Contemp Clin Trials Commun. 2022. PMID: 36387994 Free PMC article.
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.
Tahara M, Okano S, Enokida T, Ueda Y, Fujisawa T, Shinozaki T, Tomioka T, Okano W, Biel MA, Ishida K, Hayashi R. Tahara M, et al. Among authors: ueda y. Int J Clin Oncol. 2021 Oct;26(10):1812-1821. doi: 10.1007/s10147-021-01960-6. Epub 2021 Jun 24. Int J Clin Oncol. 2021. PMID: 34165660 Free PMC article. Clinical Trial.
Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study.
Uozumi S, Enokida T, Suzuki S, Nishizawa A, Kamata H, Okano T, Kawasaki T, Fujisawa T, Ueda Y, Okano S, Tahara M, Yamaguchi M. Uozumi S, et al. Among authors: ueda y. J Oncol Pharm Pract. 2024 Mar;30(2):295-303. doi: 10.1177/10781552231171699. Epub 2023 Apr 25. J Oncol Pharm Pract. 2024. PMID: 37098185
Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Sato M, Enokida T, Wada A, Okano S, Tanaka H, Fujisawa T, Ueda Y, Motegi A, Shinozaki T, Takeshita N, Tanaka N, Zenda S, Matsuura K, Akimoto T, Hayashi R, Tahara M. Sato M, et al. Among authors: ueda y. Int J Clin Oncol. 2023 Aug;28(8):1023-1032. doi: 10.1007/s10147-023-02351-9. Epub 2023 Jun 21. Int J Clin Oncol. 2023. PMID: 37344738
4,731 results